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The main messages of the article are: 
1. Most patients undergoing surgery or radio-iodine ablation for Graves’ disease 
were involved with decision making and were satisfied with their treatment. 
2. Patient involvement in the choice of definitive treatment is associated with 
increased satisfaction with treatment. 
3. Surgery is associated with higher levels of satisfaction compared to radio-iodine. 
 
Current research questions include: 
1. Factors underlying the variation in the use of surgery and radio-iodine need to be 
explored. 
2. The long term effectiveness and quality of life after definitive treatment of 
Graves’ disease is unknown 
 
Funding statement: 
This research received no specific grant from any funding agency in the public, 
commercial or not-for-profit sectors. 
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ABSTRACT: (195 words) 
Patients’ perceptions and preferences influence the choice of Radioiodine ablation 
(RIA) or surgery in the definitive management of Graves’ disease. This study aimed to 
evaluate their concerns, experiences and satisfaction following definitive treatment. 
 
A postal survey of patients who had treatment with surgery or RIA between January 
2011 and June 2013 for Graves’ disease was conducted. 
 
Of 214 patients, 136 (64%) responded. The majority of patients felt actively involved in 
decision making (83.8%) and were satisfied (84.9%) with their treatment.  Compared to 
RIA, patients who underwent surgery were more to be satisfied with their treatment 
(p=0.008). Discussion with the doctor was the most useful aid to decision making. 
Feeling involved in decision-making process was associated with improved satisfaction 
(p<0.001). 
Common reasons for not choosing surgery were need for general anaesthesia, scarring 
and voice change. Avoiding close contact, risk of persistent hyperthyroidism and 
worsening eye disease were common reasons for not choosing RIA.  Ongoing concerns 
were hypothyroidism, scarring and eye problems after surgery and hypothyroidism and 
eye problems after RIA.   
 
This study provides insight into patients’ experiences of surgery and RIA for Graves’ 
disease and reinforces the importance of patient involvement in the decision making 
process. 
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PURPOSE OF THE STUDY 
The incidence of Graves’ disease is estimated at 20-50 per 100,000 patient years and is 
increasing (1).  Management options are anti-thyroid drugs, radioiodine ablation (RIA) 
and surgery.  Anti-thyroid drugs are usually first line treatment but up to 60% relapse 
(2,3).  In patients who relapse, options include a further course of anti-thyroid drugs, 
radioiodine ablation or surgery.  Both radioiodine and surgery have advantages and 
limitations for the patients to consider.  Contraindications for surgery include 
pregnancy, recent neck surgery and severe, uncontrolled hyperthyroidism. Radioiodine 
ablation is contraindicated in pregnant or lactating women and in patients with severe 
eye disease. The choice of definitive treatment for Graves’ disease in the absence of 
specific contraindications to surgery or radioiodine seems to be influenced by patient 
and clinician preference (4-6). 
It is important to understand the reasons underlying patient preferences as well as their 
values, concerns and experiences with treatments received. This will enable clinicians to 
identify areas for improvement and help to inform future patients to facilitate decision 
making. Data on patients’ views, concerns and satisfaction with radio-iodine and 
surgical treatment of Graves’ disease is sparse. Patient satisfaction studies of 
radioiodine in the UK demonstrated that 65-87% of patients were satisfied with 
treatment and that just over half would recommend it to someone else (7,8). Patient 
reported complications included hoarseness of voice, vibrating sensation of the eyes, 
insomnia, forgetfulness, weight gain and depression (9). Other studies have 
demonstrated high satisfaction rates following surgical treatment (10,11). 
The aim of this study was to evaluate patients’ concerns, experiences and satisfaction 
with regards to both radio-iodine ablation and thyroidectomy in the definitive 
management of Graves’ disease in a single centre. 
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STUDY DESIGN 
A cross-sectional patient survey was conducted. All adult patients who had treatment 
with surgery or radio-active iodine for the management of Graves’ disease diagnosed 
between January 2011 and June 2013 at Sheffield Teaching Hospitals NHS Foundation 
Trust were included.  Participants were sent a postal questionnaire designed for this 
study.  Questions regarding patients’ concerns and reasons for choosing a particular 
treatment had predefined options as well as a free text section.  Awareness of alternative 
treatments, involvement in the decision making process, usefulness of aids to decision 
making and satisfaction with treatment were explored using 5 point Likert scales.  The 
use of radio-iodine or surgery was at the discretion of the treating endocrinologists and 
surgeons. Decisions were made in conjunction with patients following discussion of 
risks and benefits of both options.  
Radio-iodine ablation 
In uncomplicated Graves’ disease, 400MBq to 600MBq radioiodine is given depending 
on the size of the thyroid gland. In patients with eye disease, prednisolone is given to 
prevent exacerbation 2-3 days before radio-iodine treatment and continued for 3 weeks 
(30 mg per day for one week, 20 mg per day for a week, and 10 mg per day for a week).  
Advice regarding safety precautions regarding avoidance of contact with pregnant 
women and young children, in addition to return to work information is provided to all 
patients. The treatment is provided as an outpatient and response monitored in future 
visits. 
Surgery 
Total thyroidectomy is the intended procedure in all these patients.  Preoperative work 
up includes an anaesthetic assessment, laryngoscopy and biochemical tests to ensure a 
euthyroid state and a normal calcium profile. Lugol’s iodine (at a dose of 0.3ml three 
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times a day for 10 days before surgery) is routinely used to help reduce gland 
vascularity. In patients who have poor control of hyperthyroidism, monitored in-patient 
treatment with a combination of anti-thyroid drugs is carried out for 10 days before 
surgery. Patients are typically discharged the next day following a postoperative 
laryngoscopy, check of calcium levels and initiation of Thyroxine. Further follow up of 
thyroid biochemistry and any surgical complications is done in the surgical outpatient 
clinics.  
Data analysis and statistics: 
Descriptive data was reported as frequencies or percentages. Categorical variables were 
compared using the Fisher’s exact test. The levels of satisfaction, as assessed by Likert 
scale, were compared against ‘recommendation of treatment’ and ‘patient involvement 
in decision making’ using the Jonckheere-Terpstra test. The level of significance was 
set at p=0.05. 
This survey was conducted as part of a service evaluation in relation to definitive 
treatment (surgery and radio-iodine) provided in Sheffield Teaching Hospitals NHS 
Foundation Trust and was approved by the trust’s clinical effectiveness unit. As patients 
were approached by post several months after definitive treatment and those willing to 
take part in the survey did so on a voluntary basis, no additional consent process or 
application to ethics committee was involved. As this was a service evaluation, 
additional data on demographic features such as age, gender or ethnicity was not 
formally recorded. 
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RESULTS 
214 patients met the inclusion criteria.  Responses were received from 136 patients 
(64%).  79 of 111 patients (71%) who had radio-iodine and 57 of 103 patients (55%) 
who had surgery responded to the questionnaire. Table 1 shows the responses to 
questions relating to awareness of alternative treatment options, role in decision making 
and satisfaction with treatment.  
 
Decision making:  
Of the 135 responders, 108 (80%) felt that they had some or detailed understanding of 
the alternative definitive treatment option and this was significantly more often reported 
in surgical patients (p=0.007; Fisher’s exact test). 114 of 136 patients (84%) agreed or 
strongly agreed that they were actively involved in the decision making process. There 
was no significant difference between radio-iodine and surgery groups (83% vs 86%, 
Fishers’ exact test; p=0.443). There was a moderate positive correlation (Spearman’s 
rho=0.552; p<0.001) between responses to questions about ‘awareness of alternative 
option’ and ‘involvement in decision making’. 
Discussion with the doctor was considered to be the most useful decision-making tool 
for both radio-iodine and surgical patients. 92% of patients who responded agreed that it 
aided their decision making. Information leaflets (55%) and discussion with friends 
and/or family (53%) were important to over half the patients.  Over a third of patients 
(28/136; 37%) found the internet aided their decision making. Patients who underwent 
surgery were significantly more likely to report that their decision making was aided by 
“friends/family” (p=0.03; Fisher’s exact test). 
Page 7 of 21
https://mc.manuscriptcentral.com/postgradmed
Postgraduate Medical Journal
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
 
Satisfaction:  
61/79 (80%) in the radio-iodine group and 52/57 (91%) in the surgical group were 
satisfied or very satisfied with their treatment (Table 1).  Overall, patients who 
underwent surgery were significantly more satisfied with treatment compared to those 
that underwent radio-iodine (p=0.008; Fisher’s exact test). When patients were asked 
“Would you recommend your definitive treatment to others?”; there were no 
statistically significant differences between the groups (72% and 77% for radio-iodine 
and surgery respectively).  Unsurprisingly, satisfied patients were more likely to 
recommend their treatment to others than unsatisfied patients (Jonckheere-Terpstra test; 
p<0.001).  When patients agreed to feeling involved in decision-making with regards to 
treatment, they were more likely to be satisfied with treatment (Jonckheere-Terpstra 
p<0.001). 
 
Table 1. Responses to questions on awareness of alternative treatments, decision 
making and satisfaction with treatment received. 
 
 Radio-
Iodine 
 
Surgery 
 
p value 
“Awareness of alternative treatment option” n=79 n=56 
p=0.007* 
Not known another option was available 13 (17%) 2 (4%) 
Little understanding 8 (10%) 3 (5%) 
Some understanding 23 (29%) 10 (18%) 
Detailed understanding 35 (44%) 40 (71%) 
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Can’t remember 0 1 (2%) 
    
“I was involved in decision making process” n=79 n=57  
Agreed / strongly agreed 65 (83%) 49 (86%) 
p=0.443 Disagreed / strongly disagreed 8 (11%) 6 (11%) 
Unsure 6 (7%) 2 (3%) 
 
 
“The following helped you in decision making” 
 
 
 
  
Discussion with doctor 
59/67 
(88%) 
49/51 
(96%) 
p=0.18 
Leaflet 
28/52 
(54%) 
24/43 
(56%) 
p=1.0 
Friends / Family 
20/47 
(43%) 
27/41 
(66%) 
p=0.03 
Internet 
12/40 
(30%) 
16/35 
(46%) 
p=0.23 
    
“Overall satisfaction” n=76 n=57  
Very satisfied 29 (38%) 39 (68%) 
p<0.008* 
Satisfied 32 (42%) 13 (23%) 
Neutral 9 (12%) 4  (7%) 
Unsatisfied 4 (5%) 1 (2%) 
Very Unsatisfied 2 (3%) 0 
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“Would you recommend your treatment to 
others?” 
n=76 N=56  
Yes 55 (72%) 43 (77%) 
P=0.688 No 3 (4%) 3 (5%) 
Maybe 18 (24%) 10 (18%) 
    
 
 
 
 
Reported reasons for choice of treatment:  
Table 2 lists the common reasons reported by patients for not choosing radio-iodine or 
surgical treatment. There were 18 different reasons given by patients who had 
radioiodine for not choosing to have surgery.  The ‘idea of general anaesthetic and 
surgery’ was the most common (n=29) followed by scarring and voice change.  
Uncommon reasons mentioned by just one patient and not listed in table 2 included 
having chronic obstructive pulmonary disease, not preferring inpatient stay, 
effectiveness of treatment, ‘age’, recent neck surgery, stigma of surgery (not wanting to 
worry friends and family) and wanting to get back to work as soon as possible. For 
those patients who had surgery, 15 different reasons were given for not choosing radio-
iodine. Avoiding close contact with children and/or pregnant women (n=26), the risk of 
remaining overactive and worsening eye disease were the most common reasons. 
Uncommon reasons mentioned by just one patient and not listed in table 2 included the 
desire to prevent recurrent eye disease, increased uncertainty regarding hormone levels, 
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‘anxiety due to exposure’, being ‘still over-active’ despite two attempts with anti-
thyroid medications. 
 
Table 2. Common reasons for not choosing radio-iodine or surgery (in descending 
order of frequency) 
 
Patients who had radioiodine - 
reasons for not choosing surgery 
(n=77) 
N 
Patients who underwent surgery - 
reasons for not choosing radioiodine 
ablation (n=57) 
N 
Idea of general anaesthetic and 
surgery 
2
9 
Did not want to be away from 
children/pregnant women 
26 
Scarring 
1
8 
Risk of remaining overactive 25 
Voice change 
1
2 
Did not want to avoid close contact in 
general 
20 
Pain 
1
1 
Worsening eye problems 17 
Swallowing problems 8 Radioactive nature of the treatment 13 
Told by the doctor surgery was not 
an option 
8 
Was told by the doctor that RAI was not 
an option 
9 
Hypothyroidism 5 
Recommended by friends/family towards 
surgery 
4 
Recommended by friends/family 
towards RAI 
5 Development of hypothyroidism 2 
Could not take time off for the 4 Wanting to become pregnant 2 
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operation 
Radio-Iodine favoured by consultant 
in clinic 
4 Surgery favoured by doctor in the clinic 2 
Previously ‘failed thyroidectomy’ 3 Did not want steroids for the eye disease 2 
Other reasons each mentioned by 
only one patient (see text for details) 
7 
Other reasons each mentioned by only 
one patient (see text for details) 
4 
 
 
Prior and ongoing concerns with treatment received:  
Table 3 lists concerns expressed by patients relating to treatments they had actually 
received. 76 of 79 patients who underwent radioiodine responded to at least one of the 
options relating to concerns before treatment. Common concerns expressed before RIA 
treatment included ‘avoiding close contact in general’ (83%), ‘radioactive nature’ of the 
treatment (77%) and risk of ‘remaining hyperthyroid’ (59%).  75 of 79 patients 
responded to the question on ongoing concerns following RIA treatment. Common 
ongoing concerns included hypothyroidism (60%) and symptoms relating to the eyes 
(32%) and the skin (23%).  
55 of 57 surgical patients responded to at least one of the issues raised in the question 
regarding concerns before treatment. The ‘idea of general anaesthetic and surgery’ 
(63%), voice change (62%), swallowing problems (62%), scarring (58%) and 
bleeding/infection (50%) were concerns for at least half of the responders. The 55 
patients who responded to the question relating to concerns after surgery raised issues 
including ‘hypothyroidism’ (43%), scarring (32%) and problems with eyes (27%), 
swallowing (25%) and voice (23%). 
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Table 3. Concerns of patients (in percentage) before and after radioiodine or 
surgical treatment 
 
 
Concerns before 
radioiodine 
% 
Agreed 
 
Concerns before surgery 
% 
Agreed 
Avoiding close contact 
in general 83% 
 Idea of general anaesthetic 
and surgery 63% 
Radioactive nature 77%  Voice change 62% 
Avoiding 
children/pregnant 
women 76% 
 
Swallowing problems 
62% 
Remaining 
hyperthyroid 59% 
 
Scarring 
58% 
Hypothyroidism 45%  Infection/bleeding 50% 
Worsening eye 
problems 44% 
 
Pain 
48% 
Other side effects 38%  Risk of hypothyroidism 39% 
Preventing 
pregnancy/fathering 9% 
 
  
  
   
Ongoing concerns 
after radioiodine 
 Ongoing concerns after 
surgery  
Hypothyroidism 60%  Hypothyroidism  43% 
Eye problems 32%  Scarring 32% 
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Skin changes 23%  Eye problems  27% 
Hyperthyroidism 16%  Swallowing problems 25% 
Neck pain 11%  Voice change 23% 
   Neck pain 20% 
   Hyperthyroidism  19% 
   Skin changes 17% 
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DISCUSSION 
This study has shown that the majority of patients who underwent definitive treatment 
for Graves’ disease had at least some understanding of the alternative treatment option 
available to them (80%), felt involved in making the decision making process (84%) 
and were satisfied with their treatment (85%).  Other studies in Graves’ disease have 
shown similar levels of satisfaction with radioiodine and surgery (4,10). A randomised 
controlled trial from Sweden comparing medical treatment, radio-iodine and surgery in 
Graves’ disease showed that 90% of patients from each of the three treatment groups 
were satisfied with treatment (9). 
A key finding in this study was that involvement in decision-making was found to be 
positively associated with satisfaction with treatment. This has been demonstrated in 
other situations and should provide further encouragement to clinicians to ensure patient 
involvement in making treatment decisions (11-13). 
The discussion with the doctor was considered to be the most important aid in decision-
making.  Information leaflets were found to be useful in the decision making process in 
55% and the internet in 37% of patients. Given the use of internet by a significant 
proportion of patients, doctors may consider recommending reliable sources of web 
based information. Discussion with friends and family was helpful in 53%; this was 
more marked in those undergoing surgery.  The reasons for this are unclear.  
Before radioiodine treatment, the concerns related to avoiding contacts with others, 
remaining hyperthyroid and the radioactive nature of the treatment. Remaining 
hyperthyroid after radio-iodine ablation was cited as a concern by 25% of patients 
undergoing surgery and 59% of patients undergoing radio-iodine ablation. However, the 
chance of remaining hyperthyroid is reported to be less than 20% (14,15). Although, 
patients should be informed of this risk routinely, it should be reiterated that persistent 
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hyperthyroidism is uncommon and that a further dose can effectively address the 
problem. 
The idea of having surgery under general anaesthesia was the common reason for not 
undergoing surgery.  This was also a concern for 63% of patients before surgery. In 
patients undergoing surgery, the main concerns were physical complications of scarring, 
swallowing problems, voice change and neck pain (see table 3).  23% of our patients 
felt that voice change was a concern after surgery. This is similar to those in another 
study, where 29% patients believed that they had experienced voice change (10). 
Despite this, a greater number of patients were satisfied or very satisfied with surgery 
(91%) than radioiodine (80%). The higher satisfaction rates in the surgical group could 
be attributed to several reasons. Patients with more severe disease (with associated large 
goitre or thyroid eye disease) tend to be referred more often to surgery (16).  A greater 
relative improvement in well-being following treatment may therefore have contributed 
to higher scores. Patients in the surgical group are also more likely to have further 
consultations (with the surgical and anaesthetic teams in addition to endocrinologists) 
before treatment, arguably resulting in a greater opportunity to be involved in decision 
making and treatment planning. It is also likely that the surgery and radio-iodine cohorts 
are likely to differ in demographic features as radio-iodine is more likely to be used in 
elderly patients with comorbidity while surgery in the young patients with children. 
This has not been explored as the relevant data on demographics were not collected, 
given the nature of the study (service evaluation). 
The perception of being hypothyroid was the most common on-going concern raised in 
both groups.  This was greater in the radio-iodine group (60%) compared to in the 
surgery group (43%). This may be reflected in the difference between the predictability 
in developing hypothyroidism.  Following surgery, the development of hypothyroidism 
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is immediate and patients are started on thyroxine the next day. In contrast, after 
radioiodine the development of hypothyroidism may take months and is not easily 
predicted.  Patients may be concerned about when they will develop hypothyroidism 
and how it will affect them.  
This study has identified the common concerns in patients undergoing definitive 
treatment for Graves’ disease.  Clinicians should aim to provide detailed information 
and offer to discuss these issues when considering treatment options with patients.  
Addressing concerns in a shared decision making process and empowering patients will 
improve patient satisfaction with whichever treatment they undergo. Our results also 
highlight that there are a wide range of reasons for choosing RIA or surgery.  Some are 
concerns specific to only a few patients; but in these patients, they may be major factors 
in the decision making process.  In addition to common concerns, clinicians treating 
Graves’ disease should also develop strategies for exploring the less common concerns. 
The study has several limitations. The surgery group included patients from nearby 
hospitals who were referred by local endocrinologists at these hospitals specifically for 
thyroid surgery to be done by the endocrine surgeons in this centre. This may explain 
the relatively large number of patients undergoing surgery for Graves’ disease at this 
centre. As the survey was conducted around 9-39 months after definitive treatment, the 
responses are subject to recall bias. This would be particularly relevant to some 
questions such as information on the provision of information and concerns before 
treatment.  In a study of patients undergoing thyroid surgery, 69% of patients 
remembered only one or two of the possible complications mentioned prior to surgery 
and 12% could not remember any at hospital discharge.(17) The study did not use any 
validated questionnaires or scores to assess concerns such as voice, hypothyroidism or 
scar related issues as the main objective of the study was to assess overall satisfaction 
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following definitive treatment and to gain an understanding into prior and ongoing 
concerns from a patient’s perspective. Another limitation of the study is that an 
objective assessment of reported concerns was not done as it was outside the scope of 
the project. 
 
CONCLUSION 
The majority of patients are satisfied with their definitive treatment of Graves’ disease, 
but those that underwent surgery are more satisfied than those who had RIA. Reasons 
for this may be multifactorial.  The reasons underlying choice of definitive treatment 
and concerns regarding treatment are several and vary from one patient to another. 
Understanding this will improve the provision of appropriate information for patients 
and will help them in the decision making process. Patient involvement in the decision 
making is important and this involvement will increase their satisfaction with treatments 
received. 
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